BASF signs a global, exclusive supply agreement with Caregen for synthetic peptides
BASF has signed a global, exclusive supply agreement with Caregen, for four cosmetic peptides. With this expansion in it…
BASF has signed a global, exclusive supply agreement with Caregen, for four cosmetic peptides. With this expansion in it…
amcure GmbH, a biopharmaceutical company developing first-in-class cancer therapeutics, and Hinova Pharmaceuticals Inc.…
BASF Nutrition & Health and Isobionics® are launching their first joint product, Isobionics® Santalol. Thanks to its wo…
Anergis SA, a company developing Contiguous Overlapping Peptides (COPs) for ultra-fast allergy immunotherapy, and Virome…
Bachem (SIX: BANB) and Jitsubo CO., LTD. announce today that they signed an exclusive Licensing Agreement for Jitsubo’s…
BASF and Glycosyn announced its recent success in delisting Human Milk Oligosaccharide (HMO) products for Irritable Bowe…
BASF acquires aroma biotech innovation leader Isobionics BASF partners with Conagen, a leader in biotechnology research…
The 34th and, so far, biggest edition of Chemspec Europe attracted a total of 4,295 trade visitors from 53 countries to…
Founded in 2006, VelaLabs is a world -wide acting, GMP-certified and GCLP-compliant contract laboratory that offers in-d…
Today Orano Med announced that it would be investing 15 million euros in France and the United States to accelerate the…